Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
5.60
-0.21 (-3.61%)
At close: Mar 9, 2026, 4:00 PM EDT
5.64
+0.04 (0.71%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Xeris Biopharma Holdings Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | 0.55 | -54.84 | -62.26 | -94.66 | -122.73 | |
| Depreciation & Amortization | 12.69 | 12.63 | 13.16 | 12.67 | 1.88 | |
| Other Amortization | 3.37 | 3.01 | 2.21 | 1.56 | 0.96 | |
| Loss (Gain) From Sale of Assets | - | - | - | 0.24 | - | |
| Loss (Gain) From Sale of Investments | - | -0.75 | -1.26 | 0.18 | 0.41 | |
| Stock-Based Compensation | 22.37 | 18.36 | 10.72 | 12.16 | 11.38 | |
| Other Operating Activities | - | -6.57 | -3.29 | 0.11 | 0.7 | |
| Change in Accounts Receivable | -10.64 | -1.22 | -8.37 | -13.37 | -6.24 | |
| Change in Inventory | -19.29 | -8.78 | -14.8 | -7.47 | -7.42 | |
| Change in Accounts Payable | -0.07 | -9.61 | 6.96 | -4.32 | 5.53 | |
| Change in Other Net Operating Assets | 19.63 | 10.79 | 9.92 | -9.99 | 19.98 | |
| Operating Cash Flow | 28.63 | -36.98 | -47.02 | -102.89 | -95.54 | |
| Capital Expenditures | -0.7 | -0.87 | -2.26 | -0.52 | -1.09 | |
| Cash Acquisitions | - | - | - | - | 38.47 | |
| Investment in Securities | - | 5.75 | -3.74 | 34.99 | 60.58 | |
| Investing Cash Flow | -0.7 | 4.88 | -6 | 34.46 | 97.96 | |
| Long-Term Debt Issued | - | 50 | - | 146.21 | - | |
| Long-Term Debt Repaid | - | - | - | -43.5 | - | |
| Net Debt Issued (Repaid) | - | 50 | - | 102.72 | - | |
| Issuance of Common Stock | 22.27 | 1.73 | 0.58 | 30.84 | 27.84 | |
| Repurchase of Common Stock | -10.88 | -3.73 | -1.01 | -0.47 | -0.53 | |
| Other Financing Activities | - | -11.83 | -1.19 | -5.61 | -0.05 | |
| Financing Cash Flow | 11.39 | 36.17 | -1.61 | 127.47 | 27.25 | |
| Foreign Exchange Rate Adjustments | - | - | - | - | -0 | |
| Net Cash Flow | 39.32 | 4.07 | -54.64 | 59.04 | 29.67 | |
| Free Cash Flow | 27.93 | -37.85 | -49.29 | -103.42 | -96.62 | |
| Free Cash Flow Margin | 9.57% | -18.64% | -30.07% | -93.80% | -194.84% | |
| Free Cash Flow Per Share | 0.16 | -0.26 | -0.36 | -0.76 | -1.22 | |
| Cash Interest Paid | 27.12 | 26.95 | 27.69 | 10.86 | 7.29 | |
| Levered Free Cash Flow | 25.97 | -31.62 | -19.62 | -65.85 | -28.19 | |
| Unlevered Free Cash Flow | 40.77 | -15.57 | -5.2 | -58.6 | -24.67 | |
| Change in Working Capital | -10.36 | -8.82 | -6.29 | -35.15 | 11.85 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.